Connect
Discussion
Comment receiving replies
Replies to "As of the week ending November 5, more than half of new Covid-19 infections were caused..."
Transplants | Last Active: Dec 23, 2022 | Replies (76)
Comment receiving replies
As of the week ending November 5, more than half of new Covid-19 infections were caused by subvariants that Evusheld does not neutralize.
There are also concerns that the bebtelovimab monoclonal antibodies infusion will not work against the new variants. But I saw that the hospitals are being told to keep their unexpired inventory in case a new future variant coming down the road is neutralized by using it.
(It's important to keep options on the shelf when there are no replacement treatments yet.)
I don't know that the FDA will "discontinue" these drugs, but the providers may discontinue using it so patients don't get a false sense of protection.
Replies to "As of the week ending November 5, more than half of new Covid-19 infections were caused..."
Connect
@hello1234 Last week at my monthly oncologist appointment, we talked about Evusheld. Since I had my second dose in August, we will look at what is going on come February. I have had the bivalent shot also, plus a total of 4 Pfizer vaccines.
It certainly appears that protecting ourselves will be a multi-pronged approach, doesn't it? Personal protection in the form of masks, hand washing, social distancing. Careful monitoring of local conditions including flu and RSV. Constant vigilance from each of us in our own particular situations, to keep us as healthy as possible. "sigh" Never a dull moment...
Ginger